| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
2,541 |
2,329 |
$262K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
3,696 |
900 |
$173K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
3,174 |
2,898 |
$145K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
13,996 |
10,510 |
$129K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
1,753 |
1,433 |
$116K |
| 80053 |
Comprehensive metabolic panel |
11,266 |
9,223 |
$116K |
| 70450 |
Computed tomography, head or brain; without contrast material |
1,238 |
1,081 |
$113K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
345 |
278 |
$81K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
1,535 |
1,428 |
$70K |
| 87634 |
|
781 |
736 |
$62K |
| 36415 |
Collection of venous blood by venipuncture |
6,546 |
4,455 |
$53K |
| 83880 |
|
1,979 |
1,616 |
$52K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,084 |
1,009 |
$49K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,078 |
1,004 |
$49K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
1,380 |
1,173 |
$42K |
| 71046 |
Radiologic examination, chest; 2 views |
2,180 |
1,882 |
$41K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
933 |
729 |
$37K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
3,701 |
3,013 |
$36K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
835 |
771 |
$36K |
| 71045 |
Radiologic examination, chest; single view |
2,582 |
2,218 |
$35K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
436 |
271 |
$34K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
237 |
201 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,225 |
1,129 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,571 |
2,356 |
$26K |
| 80050 |
General health panel |
553 |
511 |
$25K |
| 87070 |
|
2,356 |
2,156 |
$25K |
| 84484 |
|
2,280 |
1,830 |
$23K |
| 80061 |
Lipid panel |
2,260 |
2,090 |
$22K |
| 87088 |
|
2,984 |
2,599 |
$21K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,531 |
2,358 |
$20K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
2,474 |
1,929 |
$19K |
| 81001 |
|
6,710 |
5,711 |
$19K |
| 82553 |
|
1,299 |
1,036 |
$18K |
| 82550 |
|
1,925 |
1,575 |
$17K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
497 |
449 |
$15K |
| 81025 |
|
1,783 |
1,532 |
$15K |
| 87077 |
|
2,030 |
1,776 |
$13K |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
140 |
99 |
$13K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
1,586 |
1,380 |
$13K |
| 83735 |
|
1,931 |
1,620 |
$12K |
| 84439 |
|
1,436 |
1,282 |
$11K |
| 59025 |
Fetal non-stress test |
59 |
38 |
$9K |
| 87186 |
|
1,954 |
1,719 |
$9K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
27 |
24 |
$8K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
127 |
109 |
$8K |
| 85610 |
|
2,199 |
1,669 |
$7K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
170 |
165 |
$7K |
| 86901 |
|
177 |
155 |
$7K |
| 84481 |
|
597 |
543 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
581 |
542 |
$7K |
| 85730 |
|
1,159 |
993 |
$6K |
| 86900 |
|
181 |
158 |
$6K |
| 87040 |
|
515 |
443 |
$5K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
128 |
100 |
$5K |
| 83690 |
|
583 |
498 |
$5K |
| 85027 |
|
628 |
587 |
$4K |
| 80164 |
|
461 |
413 |
$4K |
| 97161 |
|
84 |
64 |
$4K |
| 82607 |
|
311 |
273 |
$4K |
| 83605 |
|
386 |
342 |
$4K |
| 82746 |
|
421 |
383 |
$3K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
279 |
254 |
$3K |
| 94760 |
|
216 |
165 |
$3K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
30 |
28 |
$3K |
| 71020 |
|
260 |
225 |
$3K |
| 86701 |
|
257 |
244 |
$3K |
| 82728 |
|
212 |
185 |
$3K |
| 87400 |
|
445 |
410 |
$3K |
| 82150 |
|
324 |
271 |
$2K |
| 85379 |
|
236 |
208 |
$2K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
55 |
55 |
$2K |
| 86703 |
|
99 |
93 |
$2K |
| 73630 |
|
73 |
60 |
$2K |
| 83540 |
|
209 |
186 |
$1K |
| U0001 |
Cdc 2019 novel coronavirus (2019-ncov) real-time rt-pcr diagnostic panel |
35 |
34 |
$1K |
| 80076 |
|
234 |
222 |
$1K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
254 |
233 |
$1K |
| 73564 |
|
30 |
25 |
$1K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
12 |
12 |
$1K |
| 86885 |
|
173 |
151 |
$949.13 |
| 82948 |
|
180 |
108 |
$864.94 |
| 82803 |
|
27 |
24 |
$824.94 |
| 83655 |
|
48 |
46 |
$750.32 |
| 74018 |
|
35 |
26 |
$667.69 |
| 82565 |
|
58 |
47 |
$658.20 |
| 86592 |
|
122 |
117 |
$640.48 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
45 |
13 |
$595.16 |
| 84550 |
|
108 |
93 |
$557.60 |
| 87210 |
|
103 |
91 |
$543.54 |
| 73130 |
|
17 |
16 |
$496.84 |
| 72110 |
|
15 |
12 |
$481.89 |
| 74022 |
|
12 |
12 |
$471.12 |
| 82248 |
|
115 |
98 |
$460.85 |
| 86677 |
|
36 |
31 |
$451.24 |
| 85652 |
|
162 |
145 |
$443.54 |
| 86328 |
|
75 |
66 |
$432.89 |
| 87076 |
|
59 |
49 |
$425.69 |
| 80320 |
|
33 |
29 |
$398.03 |
| 83550 |
|
28 |
28 |
$350.83 |
| 82570 |
|
69 |
63 |
$347.77 |
| 87280 |
|
33 |
28 |
$347.49 |
| 84520 |
|
45 |
35 |
$295.71 |
| 74019 |
|
19 |
15 |
$281.34 |
| 73610 |
|
13 |
12 |
$248.39 |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
13 |
13 |
$208.00 |
| 84702 |
|
21 |
12 |
$196.18 |
| 82043 |
|
34 |
28 |
$194.51 |
| 80329 |
|
16 |
13 |
$184.12 |
| 71010 |
|
39 |
31 |
$180.00 |
| 87807 |
|
17 |
14 |
$169.13 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
32 |
16 |
$132.00 |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
12 |
12 |
$121.36 |
| 82950 |
|
13 |
13 |
$74.58 |
| 36416 |
|
120 |
116 |
$61.71 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
125 |
101 |
$58.31 |
| 82962 |
|
15 |
12 |
$39.33 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
46 |
38 |
$35.94 |
| 84450 |
|
28 |
26 |
$29.52 |
| 82947 |
|
12 |
12 |
$22.40 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
28 |
12 |
$4.18 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
35 |
12 |
$0.04 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
32 |
12 |
$0.04 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
25 |
25 |
$0.00 |